Polymorphisms of the androgen receptor gene and the estrogen receptor β gene are associated with androgen levels in women

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 6, 2001, Pages 2562-2568

  Westberg, Lars ^a   Baghaei, Fariba ^a   Rosmond, Roland ^a   Hellstrand, Monika ^a   Landén, Mikael ^a   Jansson, Maria ^a   Holm, Göran ^a   Björntorp, Per ^a   Eriksson, Elias ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ESTROGEN; ESTROGEN RECEPTOR; LUTEINIZING HORMONE;

ADULT; ALLELE; ANDROGEN BLOOD LEVEL; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; ANDROGENS; BASE SEQUENCE; COHORT STUDIES; ESTROGEN RECEPTOR BETA; FEMALE; FOLLICLE STIMULATING HORMONE; GONADAL STEROID HORMONES; HUMANS; LUTEINIZING HORMONE; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; SEX HORMONE-BINDING GLOBULIN; TRINUCLEOTIDE REPEATS;

EID: 0034976483     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.6.2562     Document Type: Article

References (67)

1. Androgens in polycystic ovarian syndrome
2. Polycystic ovary syndrome: Clinical perspectives and management
3. Serum androgen levels in women who have recurrent miscarriages and their correlation with markers of endometrial function
4. Polycystic ovaries and levels of gonadotrophins and androgens in recurrent miscarriage: Prospective study in 50 women
5. Androgens and women's health
6. Hormones and sexual function
7. Behavioral effects of androgens in women
8. The android woman-a risky condition
9. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function
10. Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: Possible pathogenetic relevance for the (CAG)n-expanded neuronopathies
11. Long polyglutamine tracts in the androgen receptor are associated with reduced transactivation, impaired sperm production, and male infertility
12. Inhibition of p160-mediated coactivation with increasing androgen receptor polyglutamine length
13. The CAG repeat within the androgen receptor gene and its relationship to prostate cancer
14. Polymorphic repeats in the androgen receptor gene: Molecular markers of prostate cancer risk
15. The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia
16. Androgen receptor CAG repeat length polymorphism in benign prostatic hyperplasia (BPH): Correlation with adenoma growth
17. Polymorphic CAG repeats of the androgen receptor gene and rheumatoid arthritis
18. Linkage between male infertility and trinucleotide repeat expansion in the androgen-receptor gene
19. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
20. Aberrant androgen action and increased size of tandem CAG repeat in androgen receptor gene in X-linked recessive bulbospinal neuronopathy
21. Size polymorphisms of the androgen receptor among female Hispanics and correlation with androgenic characteristics
22. Androgen receptor polymorphisms (CAG repeat lengths) in androgenetic alopecia, hirsutism, and acne
23. Genetic markers, bone mineral density, and serum osteocalcin levels
24. Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat
25. Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer
26. Finasteride and flutamide as potency-sparing androgen-ablative therapy for advanced adenocarcinoma of the prostate
27. Effect of exogenous testosterone on prostate volume, serum and semen prostate specific antigen levels in healthy young men
28. Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men
29. Oestrogen receptors: An overview
30. Dinucleotide repeat polymorphism in the human estrogen receptor (ESR) gene
31. Association of polymorphism of human alpha oestrogen receptor gene with coronary artery disease in men: A necropsy study
32. Potential role of the estrogen receptor gene (ESR1) in anxiety
33. Evidence of a linkage disequilibrium between polymorphisms in the human estrogen receptor alpha gene and their relationship to bone mass variation in postmenopausal Italian women
34. A TA repeat polymorphism in the estrogen receptor gene is associated with osteoporotic fractures but polymorphisms in the first exon and intron are not
35. Fragile X premutations and (TA)n estrogen receptor polymorphism in women with ovarian dysfunction
36. Association of estrogen receptor gene polymorphisms with endometriosis
37. Isolation and radiation hybrid mapping of dinucleotide repeat polymorphism at the human estrogen receptor beta locus
38. Association of estrogen receptor β gene polymorphism with bone mineral density
39. Polygenic inheritance and micro/minisatellites
40. Effect of postmenopausal estrogen replacement on circulating androgens
41. Exogenous estrogen and endogenous sex hormones
42. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: A clinical research center study
43. Psychiatric ill-health of women and its relationship to obesity and body fat distribution
44. Psychosocial and socio-economic factors in women and their relationship to obesity and regional body fat distribution
45. Modulation of non-templated nucleotide addition by Taq DNA polymerase: Primer modifications that facilitate genotyping
46. X-chromosome inactivation
47. Evidence for androgen receptor gene expression and growth inhibitory effect of dihydrotestosterone on human adrenocortical cells
48. The effects of prolonged hypertestosteronemia on adrenocortical biosynthesis in oophorectomized women
49. Testosterone administration increases adrenal response to adrenocorticotrophin
50. Effects of gonadal androgens and oestrogens on adrenal androgen levels
51. Effect of androgen on adrenal steroidogenesis in normal women
52. Abnormal adrenal responses to adrenocorticotropic hormone in hyperandrogenic women
53. Role of the ovary in the adrenal androgen excess of hyperandrogenic women
54. Immunohistochemical localization of androgen receptor in the human ovary throughout the menstrual cycle in relation to oestrogen and progesterone receptor expression
55. Androgens promote insulin-like growth factor-I and insulin-like growth factor-I receptor gene expression in the primate ovary
56. Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary
57. Androgens stimulate early stages of follicular growth in the primate ovary
58. Effects of flutamide on pituitary and adrenal responsiveness to corticotrophin releasing factor (CRF)
59. Flutamide in the treatment of hirsutism: Long-term clinical effects, endocrine changes, and androgen receptor behavior
60. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism
61. Inhibition of rat testicular 17α-hydroxylase and 17,20-lyase activities by anti-androgens (flutamide, hydroxyflutamide, RU23908, cyproterone acetate) in vitro
62. Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate
63. Estrogen replacement therapy decreases hyperandrogenicity and improves glucose homeostasis and plasma lipids in postmenopausal women with noninsulin-dependent diabetes mellitus
64. Immunolocalisation of oestrogen receptor beta in human tissues
65. Putative estrogen receptorβ and α mRNA expression in male and female rhesus macaques
66. Estrogen receptor null mice: What have we learned and where will they lead us?
67. Androgen insensitivity syndrome